Publications by authors named "Sushma Patel"

Claim this Profile
E
Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study.
Charlie Strange, Joseph Tkacz, Jill Schinkel, Benjamin Lewing, Barnabie Agatep, Sushma Patel

Int J Chron Obstruct Pulmon Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA study.
Edward C Portillo, Michael Pollack, Inyoung Lee, Kainan Sun, Xiaohui Zhao, Sushma Patel

Ther Adv Respir Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study.
Kristin A Evans, Michael Pollack, Edward Portillo, Charlie Strange, Daniel R Touchette, Sushma Patel

J Manag Care Spec Pharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid-based emulsion drug delivery systems - a comprehensive review.
Mori Dhaval, Poonam Vaghela, Kajal Patel, Keshvi Sojitra, Mohini Patel, Sushma Patel

Drug Deliv Transl Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRIMUS - Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation.
Joseph Tkacz, Kristin A Evans, Daniel R Touchette, Edward Portillo, Charlie Strange, Sushma Patel

Int J Chron Obstruct Pulmon Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir.
Xinyi Ng, Chizoba Nwankwo, Jean Marie Arduino, Shelby Corman, Kathryn Eilene Lasch, Sushma Patel

Patient Prefer Adherence· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.
Jan Sperl, Gabor Horvath, Waldemar Halota, Juan Arenas Ruiz-Tapiador, Anca Streinu-Cercel, Sushma Patel

J Hepatol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.
Brieana C Buckley, Derek Roylance, Matthew P Mitchell, Sushma M Patel, H Eric Cannon

J Manag Care Pharm· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency in sPLA(2) does not affect HDL levels or atherosclerosis in mice.
Charlotte A Burton, Sushma Patel, Steven Mundt, Heide Hassing, Donghui Zhang

Biochem Biophys Res Commun· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis